Skip to main content
Caplight Logo









StudyPages

StudyPages

Private
San Jose, CaliforniaHealthcare & Life Scienceshttps://studypages.com/

Last Round

Accelerator

Dec 10, 2024

Momentum

Top 10%

of companies Caplight tracks

Company Overview

StudyPages operates in Healthcare & Life Sciences and is based in San Jose, California. Its latest recorded funding round was an Accelerator round in December 2024.

StudyPages is a healthcare technology company that provides a clinical research platform designed for managing clinical trials, participant recruitment, and engagement.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

StudyPages Comparables

Compare StudyPages with similar companies based on industry and business-model similarity.

StudyPages comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Jeeva Clinical Trials Inc.
83%
Participant Kit
83%
Curebase
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

StudyPages Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 10, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

StudyPages Investors

Notable investors and investment history

StudyPages investors
InvestorRounds
PharmStarsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 32% MoM, reaching 40.2K.

  • Dec 10, 2024

    Raised an Accelerator round led by PharmStars.

Book a demo to see all signals

For institutional investors. Book with your work email.

StudyPages Filings

Explore SEC and related filing metadata, where available.

StudyPages filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about StudyPages's valuation, stock price, and market status.

Is StudyPages a public or private company?

StudyPages is a private company.

What is the current stock price of StudyPages?

StudyPages is a private company, so its shares have no public market price. Caplight tracks StudyPages's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is StudyPages worth (valuation)?

Valuation information for StudyPages is not publicly available.

Can I buy StudyPages stock?

StudyPages shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was StudyPages's last funding round?

StudyPages's most recent funding round was Accelerator on December 10, 2024.

Who are the main investors in StudyPages?

Key investors in StudyPages include PharmStars.

Will StudyPages IPO soon?

No public IPO plans have been announced for StudyPages.

How can I track StudyPages secondary market activity?

Caplight tracks bids, offers, and trades in StudyPages's shares on secondary markets.

Firmographic Details

HeadquartersSan Jose, California
Employee Range10
Year Founded2014
Last FundingDec 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?